Martingale Asset Management »

Benitec Biopharma shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $216k 16k 13.38

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
Abbvie (ABBV)
Exxon Mobil Corp
Cisco Systems (CSCO)
Visa (V)
Merck & Co (MRK)

View all positions for Martingale Asset Management

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Jupiter Topco
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Nantahala Capital Management
BlackRock
Simplify Asset Management
Vanguard Capital Management
Infinitum Asset Management
Millennium Management
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management

View all funds holding Benitec Biopharma